Roberts et al. 2013 | Epicondylitis
Back to overview
Roberts DB, Kruse RJ, Stoll SF. The effectiveness of therapeutic class IV (10 W) laser treatment for epicondylitis. Lasers Surg Med. 2013 Jul;45(5):311-7.
Randomized placebo-controlled double-blinded clinical trial. - Subjects : 16 patients with epicondylitis - Group 1: HILT - Group 2: Placebo laser - Device : LiteCure 10W HPL device - HILT Protocol : - 6.6 J/cm², total dose per session 3000 J - 8 sessions over 18 days Results: HILT group improvements at 3, 6, and 12 months respectively : • Handgrip strength: 17%, 52%, and 66% • Function: 44%, 71%, and 82% • Pain with resistance to extension of the middle finger was reduced by 50%, 93%, and 100% In contrast, NO CHANGES WERE SEEN UNTIL 12 MONTHS FOLLOWING SHAM TREATMENT. No adverse effects were reported at any time.
KEY MESSAGE: Faster reductions in pain and return of strength and function in the HP laser treatment group than in the sham group, with improvement continuing up to 1 year post-treatment.
Figures
Pubmed
iEnovis
37
© 2022 Enovis Corporation
CONFIDENTIAL
Made with FlippingBook - PDF hosting